Alnylam (ALNY) Higher on News of Possible Drug Partner
Tweet Send to a FriendGet Alerts ALNY Hot Sheet
Up)
Trade ALNY Now!
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) is moving higher on reports from Bloomberg the company is in talks with "more than one" partner to help develop its injectable high cholesterol drug.
Shares are up 1.2 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares are up 1.2 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Alnylam (ALNY) Updates on Preclinical Data for RNAi Program Targeting ALAS-1
- Potential 'Rip' Today in Transocean (RIG), Analyst has Eye on May $57.50 Calls
- UPDATE: Kansas City Southern (KSU) to Replace Dean Foods (DF) in S&P 500; WhiteWave Foods (WWAV) to S&P MidCap 400
Create E-mail Alert Related Categories
FDA, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
